News

02/14/2012 |

Spring Makes Strategic Changes to Its European Distribution Network for Its Spring Universal Infusion Sets

Spring has signed an exclusive distribution agreement with NordicInfu Care AB ("Nordicinfu"), a Swedish company, for the distribution of its Spring™ Universal Infusion Sets in the Nordic countries. The agreement replaces a previous distribution agreement for the Swedish territory and expands the distribution network to the entire Nordic region. The Company also announced that its distribution agreement with EXXE s.r.l., an Italian Company, was terminated by Spring effective as of August 15, 2012, according to its terms. D. Medical is currently in discussions with other potential distribution partners for that region.

01/25/2012 |

Spring Signs Fifth U.S. Distribution Agreement for Spring Universal Infusion Sets

Spring Health Solutions Inc. has signed a non-exclusive agreement with Solara Medical Supplies Inc. for distribution of its Spring™ Universal Infusion Sets in the United States.

About Solara Medical Supplies, Inc.

Solara Medical Supplies, Inc. is a national supplier and resource for people living with diabetes throughout the United States. Headquartered in San Diego, CA with offices in Livonia, MI and Dothan, AL, Solara provides a full range of diabetes supplies, specializing in insulin pumps, pump supplies, glucose monitors, and pump accessories. Solara's mission is to provide better management to patients with diabetes by striving to be a one-stop-shop and providing a full support team. The complete range of Solara products, including Spring Universal Infusion Set, can be purchased or sampled from Solara Medical Supplies, Inc., http://www.springinfusionsets.com or by calling 800-423-0896.

01/17/2012 |

Expansion of U.S. Distribution Network for Spring Universal Infusion Sets Continues

Spring has signed a non-exclusive agreement with Better Living Now Inc. ("BLN") for distribution of its Spring™ Universal Infusion Sets in the United States. Efri Argaman, D. Medical's Chief Executive Officer, commented, "We are pleased to enter into this relationship with BLN, a company that shares D. Medical's commitment to customer care and that has a strong presence in the U.S. diabetes distribution market. As patient interest in ground-breaking new products for diabetes management, like the Spring Universal Infusion Set, continues to grow, expanding our distribution network is key to gaining greater market access. Accordingly, the signing of this, our fourth distribution agreement in the U.S., is a key milestone achievement for our Company. We look forward to building a successful long-term working relationship with BLN."

01/11/2012 |

Spring Receives CE Mark Approval for "Spring Zone" Durable Insulin Pump

"Spring Zone" replaces Spring's first generation Spring ADI insulin pump. The proprietary Intellispring™ technology at the heart of the "Spring Zone" Insulin Delivery System results in unique performance advantages such as superior blockage and detachment detection, environmental (pressure and temperature) adaptability and continuous insulin dose delivery check. This mechanism, backed by the Total Line Control™ (TLC) safety check system, enables failsafe operation and exceptional reliability for continuously controlled and monitored insulin delivery. Other key design features that differentiate the Spring Zone from all other models on the market make it the smallest, lightest and quietest durable insulin pump.

12/05/2011 |

Spring Further Expands U.S. Distribution Network for Spring Universal Infusion Sets

Spring has signed a non-exclusive distribution agreement with Agile Edge Technologies ("AET") for the distribution of its Spring™ Universal Infusion Sets in the United States. Efri Argaman, D. Medical's Chief executive Officer, commented, "This marks our third non-exclusive distribution agreement and provides us with important new access to the governmental sector. As we continue to execute our growth strategy, expanding our U.S. distribution network and enhancing our access to additional market segments by partnering with key distributors like AET will be a key factor in our success."

11/28/2011 |

D. Medical/Spring Issued U.S. Patent No. 8050729

Spring/D. Medical announced today that it has been granted U.S. Patent No. 8050729, entitled "Devices For Continuous Measurement of Glucose in Body Fluid." This patent protects innovative technology that allows for the combination of a minimally invasive Continuous Glucose Monitor and an insulin pump on the same "patch." Amongst other features, the technology enables the use of a single access point to both accurately test for blood glucose levels and deliver insulin.

11/13/2011 |

A 3-year supply of Spring Universal Infusion Set to be donated to an uninsured family

Spring Health Solutions Inc. (Spring) is pleased to announce, as part of the World Diabetes Day, a donation of 3-year supply of its innovative Spring Universal Infusion Set and a $250 gift to Arden’s Day’s Untitled Giving Project, a project whose sole purpose is to put Insulin Pumps and Continuous Glucose Monitors in the hands of children that want but cannot afford them.

10/06/2011 |

D. Medical Expands U.S. Distribution Network for Spring Universal Infusion Sets

Spring has signed a non-exclusive distribution agreement with Doubek Medical Supply Inc. ("Doubek") for the distribution of its Spring™ Universal Infusion Sets in the United States. This agreement with Chicago-based Doubek marks the second non-exclusive U.S. distributorship established by Spring Health. The U.S. insulin pump and disposables market is large and growing. According to the American Diabetes Association, approximately 26 million diabetes patients live in the United States, constituting 8.3% of its population. Of those, experts estimate that 5.4%, or 1.4 million, suffer from Type 1 diabetes and 350,000 currently rely on insulin pump therapy. A recent U.S. Centers for Disease Control and Prevention report estimated that 1 in 3 Americans will have diabetes by 2050 if current trends continue. The annual market for infusion sets alone is estimated to total $730 million in the U.S.

09/13/2011 |

D. Medical/Spring Receives Registration Certificate From Israel's Ministry of Health For Its Spring Universal Infusion Sets

D. Medical/Spring announced today that it has received a registration certificate to market its Spring™ Universal Infusion Sets in Israel. Efri Argaman, D. Medical's Chief Executive Officer, commented, "We continue to pursue regulatory clearances for our Spring Universal Infusion Sets in various target markets in support of our goal of generating meaningful revenues and reaching positive margins as quickly as possible. Receiving this approval in our homeland, a recognized world center for Diabetes research, is particularly satisfying for us. We are now in the process of establishing a domestic distribution partnership and expect to be in a position to make this groundbreaking product commercially available here soon."

08/02/2011 |

Spring Signs First U.S. Distribution Deal for Spring Universal Infusion Sets

Spring Health Solutions Inc. has signed a non-exclusive distribution agreement with RGH Enterprises, Inc. ("RGH"), the parent company of Edgepark Medical Supplies and Independence Medical, for the distribution of its Spring™ Universal Infusion Sets in the United States. As all other steps required to make the product available in the U.S. have been successfully completed, this agreement facilitates and marks the product's immediate commercial rollout in the world's single largest insulin pump and disposables market.

Efri Argaman, D. Medical's Chief Executive Officer, commented, "The annual market for infusion sets is estimated to total $730 million in the U.S. alone – yet there has been little or no design innovation in this category in recent past. We believe that the clear advantages of our Spring Universal Infusion sets, combined with the fact that they will be available through a market leaders like Edgepark Medical Supplies and Independence Medical, will lead to maximized penetration into what was, heretofore a largely commoditized product market."

07/13/2011 |

Experience the Latest “Spring” Product Innovations at AADE Booth 1910

D. Medical/Spring will offer sampling of its recently U.S. FDA and Health Canada cleared Spring™ Universal Infusion Set, demonstrate its innovative Spring Zone insulin pump and provide a glimpse of its revolutionary Spring Hybrid Patch pump at the American Association of Diabetes Educators Annual Meeting & Exhibition, August 3-5, 2011 in Las Vegas, Booth 1910.

In May 2011, D. Medical received FDA 510(k) clearance to market the Spring Universal Infusion Sets in United States and also a medical device license to market the product in Canada. With mass production already in place, the Company expects to launch the Spring Universal Infusion Sets in the U.S. via multiple distributors over the coming weeks. With respect to Canada, D. Medical has signed a letter of intent with Dex Medical, Canada's largest distributor of diabetes care products, to become exclusive distributor of the Spring Universal Infusion Sets in Canada. While the two companies continue to work toward the signing of a final, definitive agreement, arrangements have been made with Dex Medical to make this important product available for immediate sale and delivery.

07/05/2011 |

Spring Universal Infusion Sets to Be Distributed in Canada

Spring Health Solutions Ltd. ("Spring"), has signed a non-binding letter of intent with Dex Medical, Canada's largest distributor of diabetes care products, to become exclusive distributor of the Spring Universal Infusion Set in Canada. Spring Health and Dex Medical will now enter a period of further negotiation and due diligence with the goal of entering into a final, definitive agreement.

"Patient interest in ground-breaking new products for diabetes management, like the Spring Universal Infusion Set, is increasing rapidly as the many lifestyle and clinical advantages of insulin pump therapy become more widely recognized and better established," commented Zoe Myers, Chief Commercial Officer of D. Medical. "To meet the anticipated demand in Canada, we have made arrangements with Dex Medical to make this important product available for immediate sale and delivery."

06/24/2011 |

Spring has submitted an application for CE Mark approval of its Spring™ Zone Insulin Delivery System.

"Spring Zone" replaces D. Medical's first generation Spring ADI insulin pump. The proprietary Intellispring™ technology, at the heart of the "Spring Zone" Insulin Delivery System, results in unique performance advantages such as superior blockage and detachment detection, environmental (pressure and temperature) adaptability and continuous insulin dose delivery check. This mechanism, backed by the Total Line Control™ (TLC) safety check system, enables failsafe operation and exceptional reliability for continuously controlled and monitored insulin delivery. Other key design features that differentiate the Spring Zone from all other models on the market make it the smallest, lightest and quietest durable insulin pump.

06/20/2011 |

Experience the latest Spring products at the American Diabetes Association’s 71st Scientific Sessions

Spring is pleased to announce that it will offer a sampling of its recently FDA and Health Canada cleared Spring™ Universal Infusion Set, at the American Diabetes Association's 71st Scientific Sessions being held on June 24-28 in San Diego, CA. The Company will also demonstrate its innovative Spring Zone insulin pump and provide a glimpse of its revolutionary Spring Hybrid Patch Pump. The Company Is Also Proud to Welcome "Dog4Diabetics" to its Booth 2219.

06/01/2011 |

Spring Announces Issuance of Core U.S. Patent entitled "Infusion set self-occlusion mechanism"

This patent protects the breakthrough Detach-Detect mechanism that distinguishes the recently FDA and Health Canada cleared Spring™ Universal Infusion Set from competitive products currently on the market. In the case that the base of the infusion set detaches from the user's body, a blocking mechanism is triggered which, in turn, creates an occlusion. This evokes an occlusion alarm in an insulin pump. This unique feature enables exceptional reliability for continuously controlled and monitored insulin delivery, providing additional safety and peace of mind - especially for athletes and the parents of pediatric patients.

05/24/2011 |

D. Medical's Spring Universal Infusion Sets to Be Distributed in Poland

D. Medical/Spring today announced the execution of an agreement for the distribution of its Spring™ Universal Infusion Sets in Poland. "The expansion of our global distribution network for the Spring Universal Infusion Set product is aligned with our strategy for rapid brand exposure and short term revenue generation," said Efri Argaman, D. Medical's Chief Executive Officer.

05/16/2011 |

Spring Universal Infusion Sets Receive Health Canada Medical Device License

According to the International Diabetes Federation, approximately 2.9 million diabetes patients live in Canada, constituting 11.6% of its population. That number is expected to grow considerably as the population ages. Efri Argaman, D. Medical's Chief Executive Officer, commented, "We continue to successfully execute on our low risk and low cost strategy of introducing and promoting the "Spring" brand name to and across various target markets - including the United States, Canada, Europe, Mexico and the BRIC countries of Brazil, Russia, India and China – via the commercial roll out of our Spring Universal Infusion Sets. Canada is an important market for us and we look forward to making this innovative product available there soon."

05/01/2011 |

Spring-Set Health Solutions Ltd., Receives FDA 510(k) Clearance to Market Its Spring Universal Infusion Sets in U.S.

D. Medical Industries Ltd. announced today that the U.S. Food and Drug Administration ("FDA") has granted Spring-Set Health Solutions Ltd. 510(k) clearance to market its Spring™ Universal Infusion Sets in the United States.

The Spring Universal Infusion Set is compatible with most insulin pumps currently available on the market. The Spring Universal offers best-in-class features such as a hidden, auto-retractable needle, 360° connector, and smallest one-click, all-in-one inserter.

The core of the Spring Universal Infusion Set is the proprietary Detach-Detect mechanism. This unique feature enables exceptional reliability for continuously controlled and monitored insulin delivery, providing additional safety and peace of mind - especially for athletes and the parents of pediatric patients.

04/27/2011 |

Spring Achieves Canadian Medical Devices Conformity Assessment System Certification

D. Medical Industries Ltd. announced today that its subsidiaries, Spring Health Solutions Ltd. and Spring-Set Health Solutions Ltd. ("Spring-Set"), have received Canadian Medical Devices Conformity Assessment System (CMDCAS) certification for its ISO 13485:2003 Quality System. As a result, Spring-Set is now in the process of filing an application for Health Canada approval for the Company's Universal Detach Detect Infusion Sets which Spring-Set designs and markets.

04/11/2011 |

D. Medical/Spring Issued Drug Delivery Device and Method Patent in Japan

D. Medical/ Spring announced today that it has received the Patent Certificate from the Japanese Patent Office for Japanese patent JP 468166, entitled "Drug Delivery Device and Method". The patent protects innovative methods and technologies for identifying the presence of a gas bubble in a drug delivery system, such as an insulin delivery system worn for the treatment of diabetes. Such detection provides added safety, especially for pediatric diabetes patients.

03/28/2011 |

First Product Successfully Rolls Off Mass Manufacturing Line in China

D.Medical/Spring announced today that its subcontractor, UPG (Suzhou) EPZ Co. Ltd. ("UPG"), a subsidiary of United Plastics Group, Inc., has commenced the mass production of its Spring Universal Infusion Sets in Suzhou, China.

UPG is a full service contract manufacturer in the medical, consumer, automotive and electronics market segments. Under a definitive manufacturing and supply agreement, announced on August 17, 2010, UPG is supplying Spring, as a non-exclusive supplier, with the Spring Universal Infusion Sets. UPG's production and supply of the consumable components of D. Medical's Spring Adi durable insulin pump and, when available, its Spring Hybrid Patch Pump, is expected to be launched under the aforementioned agreement later this year.

03/27/2011 |

Spring to present poster at the Clinical Diabetes Technology Meeting

Use of an automatic, hidden, auto-retractable needle in an infusion set such as Spring Universal used for subcutaneous administration of medicine provides the user with enhanced safety, confidence, and psychological well-being.
See this poster presentation at the
Clinical Diabetes Technology Meeting
April 8-9 in Philadelphia

http://www.clinicaldiabetestechnology.org/

02/09/2011 |

D. Medical's Revolutionary "Spring Hybrid Patch" Pump Solution to be Officially Unveiled at ATTD 2011

D. Medical Industries Ltd. today announced that the Company's Chief Operating Officer, Hezkiah Tsoory, has been chosen to present at the Fourth International Conference on Advanced Technologies and Treatments for Diabetes ("ATTD 2011") to take place at the Hilton London Metropole hotel in London, UK on February 16-19, 2011. Mr. Tsoory's presentation will take place in Hall at 8:15 am on Saturday, February 19, 2011.

Based on an abstract entitled, "Spring - a patch pump without a motor", Mr. Tsoory's presentation will highlight the Company's new "Spring Hybrid" insulin pump solution. The innovative Intellispring™ technology that has been implemented in D. Medical's traditional ADI CSII system has now been transformed into the world's first ever "convertible" continuous insulin delivery system. It is convertible because it can be worn either as a patch pump or as a durable pump.

02/07/2011 |

Spring-Set Health Solutions Ltd., Achieves ISO 13485:2003 and ISO 9001:2008 Certifications

D. Medical Industries Ltd. announced today that its subsidiary, Spring-Set Health Solutions Ltd. (formerly "Medx- Set Ltd."), has achieved ISO 13485:2003 and ISO 9001:2008 certifications. Spring-Set designs and markets the Company's Universal Detach Detect Infusion Sets. ISO 13485:2003 is an internationally recognized standard developed to ensure that companies provide medical devices that consistently meet regulatory requirements. In order to obtain the certification, Spring-Set demonstrated the ability to consistently meet strict requirements for Quality Management Systems (QMS) applicable to medical device manufacturing and related services.

01/10/2011 |

Spring Universal Infusion Set to be distributed in Sweden

Spring Health Solutions Ltd., today announced the successful bid by its Swedish distributor for the marketing and sales of Spring Universal Detach Detect Infusion Sets in Sweden.

"This successful bid not only represents an important early revenue opportunity for D. Medical, but also validates the advantages of our Spring Universal Detach Detect Infusion Sets and enhances our distributor's ability to market and sell our products and promote D. Medical's 'Spring' brand name throughout Sweden," said Efri Argaman, D. Medical's Chief Executive Officer.

12/06/2010 |

D. Medical/Spring hires Chief Commercial Officer

Accomplished U.S. Diabetes Industry Veteran, Zoe H. Myers, Joins D. Medical as Chief Commercial Officer. Effective February 1, 2011. Ms. Myers' responsibilities will include leading global commercial strategy and U.S. operations for D. Medical. Ms. Myers is an international business leader with an accomplished history of opening new markets for novel diabetes devices. She joins D. Medical from her current position as Advisor at MC2 Consulting, Inc., a consulting firm that manages the full product lifecycle, including the development of business and marketing plans, for emerging R&D companies.

10/17/2010 |

Spring Products to Be Distributed in Greece

D-Medical/Spring, today announced the execution of a distribution agreement with Pharmaserve-Lilly S.A.C.I. ("Pharmaserve-Lilly") for the distribution of its Spring ADI durable insulin pump, related consumables and its Spring Universal Detach Detect Infusion Sets in Greece.

The agreement has an initial term of three years, commencing on the date of the distributor's initial order, and will thereafter be automatically renewed for one-year periods, unless either party notifies the other of its desire not to renew six months in advance. In addition, each party may terminate the agreement upon 180-days' prior written notice to the other party. The agreement is mutually exclusive and the parties have agreed to set a yearly sales target.